Composition (per tablet):

Glimepiride 2 mg,Metformin Hydrochloride 500 mg,Voglibose 0.2 mg
Manufacturer: Alkem Laboratories Ltd.

Description:

Glimikem MV2 Tablet is a triple combination oral antidiabetic medication that contains Glimepiride, Metformin, and Voglibose.
This combination provides comprehensive glycemic control in Type 2 Diabetes Mellitus (T2DM) by addressing insulin secretion, insulin resistance, and postprandial glucose spikes.

Warnings & Precautions:

Risk of hypoglycemia, particularly in elderly or undernourished patients.

Regularly monitor blood glucose and HbA1c.

Avoid excessive alcohol intake (risk of lactic acidosis due to Metformin).

Use with caution in renal impairment; assess renal function before and during therapy.

Discontinue temporarily in cases of infection, surgery, or radiological contrast studies.

Adverse Effects:

Common: Hypoglycemia, nausea, flatulence, diarrhea, abdominal discomfort.

Occasional: Headache, dizziness, mild rash.

Rare: Lactic acidosis (Metformin), hepatic dysfunction, hypersensitivity reactions.

Storage:

Store below 25°C, protected from light and moisture.
Keep out of reach of children.